Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Dave Nicholls"'
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 1, Pp 35-64 (2020)
Abstract The act of nonmedical switching, defined as switching stable patients who are generally doing well with their current therapy from an originator biologic to its biosimilar, has been endorsed as a reasonable treatment strategy. The safety and
Externí odkaz:
https://doaj.org/article/301392aadbb844ddac2bc06f48eea1f1
Autor:
Lynden Roberts, Kathleen Tymms, Julien de Jager, Geoffrey Littlejohn, Hedley Griffiths, Dave Nicholls, Paul Bird, Jennifer Young, Julie Hill, Jane Zochling
Publikováno v:
International Journal of Rheumatology, Vol 2017 (2017)
Objectives. To observe the choices of conventional disease modifying antirheumatic drugs (cDMARDs) and biologic DMARDs (bDMARDs) in the management of rheumatoid arthritis (RA) in Australian routine clinical practice, to assess treatment survival and
Externí odkaz:
https://doaj.org/article/71eee8aced7546baae14907410b37f69
Autor:
Dave Nicholls, Seán Manning
Publikováno v:
Ata: Journal of Psychotherapy Aotearoa New Zealand. 24:43-61
Beginning with the experience of working with men in prison and others who have considerable prison experience, all of whom have long criminal histories, and considering Aotearoa’s relatively high rate of imprisonment, particularly of indigenous pe
Autor:
Josef S Smolen, Dave Nicholls, Daniel Aletaha, Jen-Fue Maa, Stefan Florentinus, Sung-Hwan Park, Su Chen, Daniel Furtner
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo determine if disease duration and number of prior disease-modifying antirheumatic drugs (DMARDs) affect response to therapy in patients with established rheumatoid arthritis (RA).MethodsAssociations between disease duration or number of
Autor:
Peter Button, Lynden J. Roberts, Rina Barrett, Dave Nicholls, Geoffrey O. Littlejohn, Matt Truman, Kathleen Tymms, Paul Bird, H. Griffiths
Publikováno v:
Internal Medicine Journal. 48:1185-1192
Background The comparative effectiveness of biologic treatment regimens in a real world Australian population is unknown. Aim To assess the effectiveness of biological disease-modifying anti-rheumatic drugs (bDMARD) as monotherapy or in combination w
Autor:
Kathleen Tymms, Philip McCloud, Dave Nicholls, Lynden J. Roberts, Julien de Jager, Paul Bird, H. Griffiths, Geoffrey O. Littlejohn, Rina Barrett
Publikováno v:
International Journal of Rheumatic Diseases. 20:460-468
Aim: To assess the association between baseline clinical prognostic factors and subsequent Disease Activity Score of 28 joints (DAS28) remission in early rheumatoid arthritis (RA). Methods: Data were collected using point of care clinical software fr
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 7, Iss 1, Pp 35-64 (2020)
Rheumatology and Therapy, Vol 7, Iss 1, Pp 35-64 (2020)
The act of nonmedical switching, defined as switching stable patients who are generally doing well with their current therapy from an originator biologic to its biosimilar, has been endorsed as a reasonable treatment strategy. The safety and efficacy
Autor:
Dave Nicholls, Filip Maric
Publikováno v:
Physiotherapy theory and practice. 35(10)
Unlike any other time in the history of humanity, today’s world is marked by unprecedented environmental crises. Climate change, melting of polar ice caps, plastic waste polluting the oceans and ot...
Autor:
Dave, Nicholls, Rina, Barrett, Peter, Button, Matt, Truman, Paul, Bird, Lynden, Roberts, Kathleen, Tymms, Geoffrey, Littlejohn, Hedley, Griffiths
Publikováno v:
Internal medicine journal. 48(10)
The comparative effectiveness of biologic treatment regimens in a real world Australian population is unknown.To assess the effectiveness of biological disease-modifying anti-rheumatic drugs (bDMARD) as monotherapy or in combination with methotrexate
Autor:
Dave Nicholls, Julien de Jager, Paul Bird, Simon Burnet, Lynden J. Roberts, James Scott, H. Griffiths, Jane Zochling, Geoffrey O. Littlejohn, Kathleen Tymms, M. H. Arnold
Publikováno v:
Arthritis Care & Research. 66:190-196
Objective: To evaluate barriers that prevent rheumatoid arthritis (RA) patients from achieving Disease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR) scores within the current recommended levels for low disease activ